Joseph Patrick McEvoy

Professor

  • 24194 Citations
  • 76 h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Schizophrenia Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
olanzapine Medicine & Life Sciences
Psychotic Disorders Medicine & Life Sciences
Risperidone Medicine & Life Sciences
Haloperidol Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities

Anderson, K. E., Stamler, D., Davis, M. D., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Dopamine Antagonists
Comorbidity
Psychotic Disorders
Psychiatry
Mood Disorders

35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia

Anderson, K. E., Stamler, D., Davis, M. D., Gross, N., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, p. 193-194 2 p.

Research output: Contribution to journalArticle

Open Access
Placebos
Therapeutics
Dyskinesias
deutetrabenazine
Tardive Dyskinesia

Characterizing treatment effects of valbenazine for tardive dyskinesia: Additional results from the KINECT 3 study

Correll, C. U., Cutler, A. J., Kane, J. M., McEvoy, J. P., Liang, G. S. & O'Brien, C. F., Jan 1 2019, In : Journal of Clinical Psychiatry. 80, 1

Research output: Contribution to journalArticle

Placebos
Body Regions
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics
Odds Ratio

The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders

McEvoy, J. P., Park, T., Schilling, T., Terasawa, E., Ayyagari, R. & Carroll, B., Jan 1 2019, In : Current Medical Research and Opinion.

Research output: Contribution to journalArticle

Mental Disorders
Antipsychotic Agents
Inpatients
Delivery of Health Care
Tardive Dyskinesia

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 othersBuckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

Prolactin
Psychotic Disorders
Clinical Trials
Placebos
Galactorrhea